MacroGenics, Inc.
MGNX
$1.31
-$0.06-4.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 154.05M | 149.96M | 141.33M | 41.02M | 43.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 154.05M | 149.96M | 141.33M | 41.02M | 43.36M |
| Cost of Revenue | 101.36M | 97.83M | 100.96M | 92.04M | 89.33M |
| Gross Profit | 52.69M | 52.14M | 40.37M | -51.02M | -45.97M |
| SG&A Expenses | 67.06M | 71.05M | 55.80M | 54.10M | 53.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 253.50M | 260.54M | 248.42M | 237.81M | 226.93M |
| Operating Income | -99.45M | -110.58M | -107.09M | -196.79M | -183.57M |
| Income Before Tax | -54.87M | -66.02M | -97.62M | -136.37M | -23.24M |
| Income Tax Expenses | 944.00K | 944.00K | -- | -- | -- |
| Earnings from Continuing Operations | -55.81 | -66.97 | -97.62 | -136.37 | -23.24 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -55.81M | -66.97M | -97.62M | -136.37M | -23.24M |
| EBIT | -99.45M | -110.58M | -107.09M | -196.79M | -183.57M |
| EBITDA | -91.98M | -103.04M | -99.71M | -189.29M | -175.07M |
| EPS Basic | -0.89 | -1.07 | -1.57 | -2.19 | -0.37 |
| Normalized Basic EPS | -0.91 | -1.02 | -0.98 | -1.37 | -0.23 |
| EPS Diluted | -0.89 | -1.08 | -1.58 | -2.19 | -0.38 |
| Normalized Diluted EPS | -0.91 | -1.02 | -0.98 | -1.37 | -0.23 |
| Average Basic Shares Outstanding | 251.16M | 250.48M | 249.74M | 248.98M | 248.20M |
| Average Diluted Shares Outstanding | 251.28M | 250.60M | 249.86M | 249.24M | 248.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |